Intervention

Authors
Category Primary study
Registry of TrialsIranian Registry of Clinical Trials
Year 2020
INTERVENTION: Intervention 1: Intervention group: Products containing 10 mg of methanolic extract plus 450 mg of propolis will be prescribed three times a day for each patient. This amount of active ingredients is dissolved in 30cc of simple BP syrup. This 30 cc is ordered in 10cc (one tablespoon) every 8. The time will be prescribed. The formulated syrup will be given to the patients in the amount of 60 cc required by the above‐mentioned order for 2 days and the patients will go to the clinic every two days after receiving the medicine again, the questionnaire and clinical symptoms will be referred to the clinic. In addition, suspected patients with covid 19 will be delivered to patients after the approval of an infectious disease specialist and, if the patient agrees, and will receive a signature and fingerprint in the syrup consent form. Prescribing syrup and examining the patient's symptoms are 6 days. Intervention 2: Control group: Simple BP syrup (without therapeutic products) will be prescribed every 10 hours with a 10cc (one tablespoon) recipe. Two days later, the drug will be returned to the clinic, a questionnaire and clinical signs will be sent to the clinic. In addition, suspected patients with covid 19 will be delivered to patients after the approval of an infectious disease specialist and, if the patient agrees, and will receive a signature and fingerprint in the syrup consent form. Prescribing syrup and examining the patient's symptoms are 6 days. CONDITION: covid 19. ; Covid‐19 U07.1 PRIMARY OUTCOME: Shortness of breath, medicine, dry cough, chills and etc. Timepoint: May and June. Method of measurement: Quantitative and qualitative. INCLUSION CRITERIA: The patient must have a voluntary consent to participate in operation; The patient's clinical symptoms such as: dry cough, shortness of breath, fever, shortness of breath, fatigue, etc. in suspected or associated with COVID‐19 is evaluated after treatment and these symptoms are compared with placebo group.
Epistemonikos ID: 9e2f9193a95f8d907eeb39c2c82ebc7ba970f14c
First added on: May 18, 2020